Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.19 CAD | +2.70% | +2.70% | +8.57% |
06-20 | Theralase Technologies Inc. Announces Rutherrin Repurposes Non-Cancer Drugs for Cancer Therapy | CI |
06-12 | Theralase Technologies Inc. Announces Rutherrin Increases Efficacy of Chemotherapy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.57% | 33.2M | |
-3.95% | 793M | |
-31.56% | 212M | |
0.00% | 125M | |
-25.00% | 86.29M |
- Stock Market
- Equities
- TLT Stock
- News Theralase Technologies Inc.
- Theralase Technologies : Says Chief Executive Shirazi Leaving Company; John Trikola Appointed Interim CEO